Type-specific roles of histone deacetylase (HDAC) overexpression in ovarian carcinoma: HDAC1 enhances cell proliferation and HDAC3 stimulates cell migration with downregulation of E-cadherin

作者: Akiko Hayashi , Akiko Horiuchi , Norihiko Kikuchi , Takuma Hayashi , Chiho Fuseya

DOI: 10.1002/IJC.25151

关键词: Histone deacetylase 2CadherinHistoneHistone deacetylaseChromatinCell growthOvarian carcinomaCyclin ACancer researchBiology

摘要: Histone acetylation/deacetylation controls chromatin activity and subsequent gene transcription. Recent studies demonstrated the activation of histone deacetylases (HDACs) in various human malignancies; however, expression function HDACs ovarian tumors are not fully understood. In this study, we examined immunohistochemical HDAC1, HDAC2 HDAC3 using tissues obtained from 115 cases compared it with that Ki-67 (a growth marker), p21, E-cadherin clinicopathological parameters. addition, analyzed effect specific siRNA for on cell cycle-related molecules to clarify functional difference among 3 HDACs. The results indicated nuclear proteins increased stepwise benign, borderline malignant tumors. HDAC1 was correlated inversely expression. Among examined, only associated a poor outcome, when overexpressed. Treatment HDAC inhibitors suppressed proliferation cancer cells association apoptosis. A significantly reduced carcinoma via downregulation cyclin expression, but migration elevated Our suggested plays an important role cells, whereas functions adhesion migration. Therefore, therapeutic approaches should be considered according subtypes.

参考文章(64)
William M Grady, Joseph Willis, Parry J Guilford, Anita K Dunbier, Tumi T Toro, Henry Lynch, Georgia Wiesner, Kelly Ferguson, Charis Eng, Jae-Gahb Park, Seong-Jin Kim, Sanford Markowitz, None, Methylation of the CDH1 promoter as the second genetic hit in hereditary diffuse gastric cancer. Nature Genetics. ,vol. 26, pp. 16- 17 ,(2000) , 10.1038/79120
Karl-Friedrich Becker, Ingrid Becker, Michael J. Atkinson, Jörg R. Siewert, Ulrike Reich, Hjalmar Nekarda, Heinz Höfler, E-cadherin gene mutations provide clues to diffuse type gastric carcinomas. Cancer Research. ,vol. 54, pp. 3845- 3852 ,(1994)
Karen G. Louie, Robert F. Ozols, Brent C. Behrens, Takashi Tsuruo, Thomas C. Hamilton, Robert C. Young, Collateral susceptibility of adriamycin-, melphalan- and cisplatin-resistant human ovarian tumor cells to bleomycin. Japanese Journal of Cancer Research. ,vol. 77, pp. 941- 945 ,(1986) , 10.20772/CANCERSCI1985.77.9_941
Sharon L R Kardia, David E. Misek, Samir M. Hanash, George Michailidis, Rork Kuick, Eric R. Fearon, Kerby A. Shedden, Thomas J. Giordano, Danielle M. Darrah, Kathleen R. Cho, Yali Zhai, Jeremy M G Taylor, Lora H. Ellenson, Heather Reed, Donald R. Schwartz, Rong Wu, Gene expression in ovarian cancer reflects both morphology and biological behavior, distinguishing clear cell from other poor-prognosis ovarian carcinomas. Cancer Research. ,vol. 62, pp. 4722- 4729 ,(2002)
Wilko Weichert, Carsten Denkert, Aurelia Noske, Silvia Darb-Esfahani, Manfred Dietel, Steve E. Kalloger, David G. Huntsman, Martin Köbel, Expression of class I histone deacetylases indicates poor prognosis in endometrioid subtypes of ovarian and endometrial carcinomas. Neoplasia. ,vol. 10, pp. 1021- 1027 ,(2008) , 10.1593/NEO.08474
Kristen Jepsen, Michael G. Rosenfeld, Biological roles and mechanistic actions of co-repressor complexes. Journal of Cell Science. ,vol. 115, pp. 689- 698 ,(2002) , 10.1242/JCS.115.4.689
A Jeanes, C J Gottardi, A S Yap, Cadherins and cancer: how does cadherin dysfunction promote tumor progression? Oncogene. ,vol. 27, pp. 6920- 6929 ,(2008) , 10.1038/ONC.2008.343
Jessica E. Bolden, Melissa J. Peart, Ricky W. Johnstone, Anticancer activities of histone deacetylase inhibitors Nature Reviews Drug Discovery. ,vol. 5, pp. 769- 784 ,(2006) , 10.1038/NRD2133
C Schröder, K Eckert, H R Maurer, Tributyrin induces growth inhibitory and differentiating effects on HT-29 colon cancer cells in vitro. International Journal of Oncology. ,vol. 13, pp. 1335- 1340 ,(1998) , 10.3892/IJO.13.6.1335
Amy L. Cooper, Victoria L. Greenberg, Pamela S. Lancaster, John R. van Nagell, Stephen G. Zimmer, Susan C. Modesitt, In vitro and in vivo histone deacetylase inhibitor therapy with suberoylanilide hydroxamic acid (SAHA) and paclitaxel in ovarian cancer. Gynecologic Oncology. ,vol. 104, pp. 596- 601 ,(2007) , 10.1016/J.YGYNO.2006.09.011